| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $507.4M | +32.3% |
| Cost of Revenue | $111.8M | +18.9% |
| Gross Profit | $282.8M | -2.3% |
| R&D Expense | $150.6M | +10.4% |
| SG&A Expense | $331.7M | +27.0% |
| Operating Income | -$199.6M | -63.1% |
| Pre-tax Income | -$193.0M | -32.6% |
| Income Tax | -$5.4M | -794.0% |
| Net Income | -$187.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $90.8M | -46.5% |
| Accounts Receivable | $108.6M | +78.8% |
| Inventory | $63.6M | +10.2% |
| Current Assets | $475.0M | +5.6% |
| Total Assets | $893.5M | -8.3% |
| Current Liabilities | $101.3M | +34.8% |
| Total Liabilities | $237.3M | +14.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.8M | +75.9% |
| Capital Expenditures | $7.7M | +21.7% |
| Investing Cash Flow | -$77.6M | -262.3% |
| Financing Cash Flow | $11.9M | -87.0% |
| Free Cash Flow | -$22.5M | +66.8% |
| -28.2% |
| EPS (Basic) | -$3.28 | -18.4% |
| EPS (Diluted) | -$3.28 | -18.4% |
| Stockholders' Equity |
| $656.2M |
| -14.4% |